Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
T. Rowe Price Investment Management, Inc. AVTR Avantor, Inc. 13G/A 7.8% 2y
Clal Insurance Enterprises Holdings Ltd ESLT Elbit Systems Ltd 13G/A 4.3% 2y
BROWN CAPITAL MANAGEMENT LLC VCEL Vericel Corp 13G/A 14.29% 2y
OpenView Management, LLC EXFY Expensify, Inc. 13G/A 0% 2y
Haim Siboni FRSX Foresight Autonomous Holdings Ltd. 13G/A 9.2% 2y
BAKER BROS. ADVISORS LP BMEA Biomea Fusion, Inc. 13G/A 5.9% 2y
AQR CAPITAL MANAGEMENT LLC SPKLF Spark I Acquisition Corp 13G 6% 2y
COHEN & STEERS, INC. TCN Tricon Residential Inc. 13G/A 0% 2y
FIR TREE CAPITAL MANAGEMENT LP CHAA Catcha Investment Corp 13G 9.23% 2y
Lynx1 Capital Management LP ALPN Alpine Immune Sciences, Inc. Common Stock 13G/A 6.6% 2y
Park West Asset Management LLC SPWR SunPower Inc. 13G/A 6.9% 2y
GLAZER CAPITAL, LLC ZCAR Zoomcar Holdings, Inc. 13G/A 0% 2y
Daniel A. Schreiber LMND Lemonade, Inc. 13G/A 2.7% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SMHI SEACOR Marine Holdings Inc. 13G/A 14.8% 2y
Walleye Capital LLC GCTS GCT Semiconductor Holding, Inc. 13G 6.62% 2y
AMERIPRISE FINANCIAL INC AIOT Powerfleet, Inc. 13G 6.42% 2y
LONDON CO OF VIRGINIA NEU Newmarket Corp 13G/A 6.9% 2y
R. Kirk Huntsman VVOS Vivos Therapeutics, Inc. 13G/A 4.3% 2y
GLENVIEW CAPITAL MANAGEMENT, LLC BKD Brookdale Senior Living Inc. 13G/A 9% 2y
Divisadero Street Capital Management, LP JAKK Jakks Pacific Inc 13G/A 0% 2y
Energy Income Partners, LLC CWEN Clearway Energy, Inc. 13G 5.8% 2y
SILVERCREST ASSET MANAGEMENT GROUP LLC ICFI ICF International, Inc. 13G/A 4.96% 2y
Redmile Group, LLC TRDA Entrada Therapeutics, Inc. 13G/A 3.8% 2y
Select Equity Group, L.P. DAY Dayforce, Inc. 13G/A 9.6% 2y
HHLR ADVISORS, LTD. ALGS Aligos Therapeutics, Inc. 13G/A 8.2% 2y
AMERIPRISE FINANCIAL INC GAIA Gaia, Inc 13G/A 6.67% 2y
Portolan Capital Management, LLC KRUS Kura Sushi USA, Inc. 13G/A 0.74% 2y
Golden Stone Capital Limited ICG Intchains Group Ltd 13G 32.5% 2y
Venrock Healthcare Capital Partners III, L.P. ELVN Enliven Therapeutics, Inc. 13G/A 7.2% 2y
TIAA-CREF Investment Management, LLC ARCO Arcos Dorados Holdings Inc. 13G/A 6.74% 2y
NOVO HOLDINGS A/S EVO Evotec SE 13G/A 8.4% 2y
Radcliffe Capital Management, L.P. CFIV CF Acquisition Corp. IV Class A common stock 13G/A 0% 2y
Mehana Capital LLC SBC SBC Medical Group Holdings Inc 13G 67.28% 2y
BAKER BROS. ADVISORS LP KALA KALA BIO, Inc. 13G/A 9.99% 2y
CONTINENTAL GENERAL INSURANCE CO ASRT Assertio Holdings, Inc. 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ DG Dollar General Corp 13G/A 8.3% 2y
REDWOOD CAPITAL MANAGEMENT, LLC GASS StealthGas Inc. 13G/A 0% 2y
Equinox Partners Investment Management LLC ITRG Integra Resources Corp. 13G/A 10.3% 2y
Two Seas Capital LP ABUS Arbutus Biopharma Corp 13G/A 5.4% 2y
EARNEST PARTNERS LLC EFSC Enterprise Financial Services Corp 13G/A 5.2% 2y
WYNNCHURCH CAPITAL PARTNERS IV, L.P. SWIM Latham Group, Inc. 13G/A 13.1% 2y
First Trust Capital Management L.P. VMCAF Valuence Merger Corp. I 13G 9.9% 2y
T. Rowe Price Investment Management, Inc. HLIO Helios Technologies, Inc. 13G 6.4% 2y
RA CAPITAL MANAGEMENT, L.P. CMRX Chimerix, Inc. 13G/A 9.9% 2y
SCOGGIN MANAGEMENT LP MNTS Momentus Inc. 13G/A 4.57% 2y
TANG CAPITAL MANAGEMENT, LLC KALV KalVista Pharmaceuticals, Inc. 13G/A 9.96% 2y
ARMISTICE CAPITAL, LLC ACXP Acurx Pharmaceuticals, Inc. 13G/A 4.99% 2y
BAKER BROS. ADVISORS LP ALGS Aligos Therapeutics, Inc. 13G/A 4.99% 2y
Cormorant Asset Management, LP AMAM Ambrx Biopharma, Inc. Common Stock 13G/A 17.78% 2y
Radcliffe Capital Management, L.P. OPTX Syntec Optics Holdings, Inc. 13G/A 0% 2y